Technical Analysis for GTG - Genetic Technologies Limited

Grade Last Price % Change Price Change
grade D 0.005 0.00% 0.000
GTG closed unchanged on Friday, August 16, 2019, on 3.28 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical GTG trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Volume Surge Other 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for GTG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart
Profile
Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.
Medicine Biotechnology Cancer Clinical Medicine Imaging Breast Cancer Healthcare Professionals Medical Tests Molecular Diagnostics
Is GTG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.017
52 Week Low 0.004
Average Volume 5,032,055
200-Day Moving Average 0.0077
50-Day Moving Average 0.0062
20-Day Moving Average 0.0055
10-Day Moving Average 0.005
Average True Range 0.0007
ADX 23.35
+DI 17.1875
-DI 39.0625
Chandelier Exit (Long, 3 ATRs ) 0.0039
Chandelier Exit (Short, 3 ATRs ) 0.0061
Upper Bollinger Band 0.0065
Lower Bollinger Band 0.0045
Percent B (%b) 0.25
BandWidth 36.363636
MACD Line -0.0003
MACD Signal Line -0.0004
MACD Histogram 0.0001
Fundamentals Value
Market Cap 12.18 Million
Num Shares 2.44 Billion
EPS 0.00
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 24.33
Price-to-Book 1.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.007
Resistance 3 (R3) 0.006 0.006 0.006
Resistance 2 (R2) 0.006 0.005 0.006 0.006
Resistance 1 (R1) 0.005 0.005 0.006 0.006 0.006
Pivot Point 0.005 0.005 0.005 0.005 0.005
Support 1 (S1) 0.004 0.004 0.005 0.005 0.004
Support 2 (S2) 0.004 0.004 0.004 0.004
Support 3 (S3) 0.003 0.004 0.004
Support 4 (S4) 0.004